文献速递头颈外科咽喉与嗓音

cT1-cT2 N0 声门上型喉鳞状细胞癌淋巴结活检的可靠性与结局

Reliability and outcomes of lymph nodes biopsy in cT1-cT2 N0 supraglottic laryngeal squamous cell carcinoma.
PubMed 文献 · Head Neck · 2024-02-29

该研究回顾性分析2003至2019年CHU Godinne的39例临床N0声门上型喉鳞状细胞癌患者,评估前哨淋巴结活检(SNB)的可靠性。SNB在全部39例中成功识别前哨淋巴结,2年颈部无复发生存率为95%,敏感度82%、阴性预测值94%,作者认为该技术在早期N0患者中可行且可靠,但需进一步前瞻性对照研究确立其肿瘤学等效性。

要点

  • SNB敏感度为82%,阴性预测值为94%,2年颈部无复发生存率为95%。
  • 作者认为SNB在早期N0声门上型喉鳞状细胞癌中可行且可靠,但需进一步前瞻性对照研究。

核心结论

  • 结果表明,SNB在T1-T2声门上型喉鳞状细胞癌N0早期患者颈部管理中是一项可行且可靠的技术。
  • 要确立其与选择性颈淋巴结清扫的肿瘤学等效性,尚需进一步前瞻性对照研究。

研究设计与样本

  • 回顾性分析2003至2019年在CHU Godinne接受手术的39例临床N0声门上型喉鳞状细胞癌患者。
  • SNB流程包括全身麻醉、瘤周注射99-锝胶体及淋巴显像,肿瘤切除后同台手术中使用手持伽马探头行SNB。
  • 39例中36例仅以SNB作为分期工具,3例接受SNB联合选择性颈淋巴结清扫。

主要发现

  • 全部39例均成功识别前哨淋巴结,平均每例切除4枚淋巴结。
  • 23%(39例中9例)检出前哨淋巴结阳性,随后行选择性颈淋巴结清扫。
  • 观察到2例颈部复发,均视为假阴性,平均发生于3.5个月后。
  • 中位随访48个月,2年颈部无复发生存率为95%,SNB敏感度为82%、阴性预测值为94%。
  • 2年和5年疾病特异性生存率分别为84%和71.7%。

临床怎么用

  • 作者认为SNB在T1-T2声门上型喉鳞状细胞癌N0早期患者颈部管理中可行且可靠。
  • 作者指出,要确立SNB与选择性颈淋巴结清扫的肿瘤学等效性,尚需进一步前瞻性对照研究。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In oral and oropharyngeal squamous cell carcinoma (SCC), sentinel node biopsy (SNB) was described as a reliable and reproductive alternative to elective neck dissection for the staging of clinical N0 T1-T2 patients. The SNB technique in supraglottic laryngeal SCC was successfully described in small series. The aim of this study is to analyze retrospectively the results of SNB technique in supraglottic SCC in CHU Godinne, to determine if the technique is reliable and may be proposed in a future multicentral prospective trial. METHODS: The study involved a retrospective analysis of 39 patients who underwent surgery between 2003 and 2019 at CHU Godinne. All patients presented with clinical N0 neck status. The SNB procedure included general anesthesia, 99-technetium colloid peritumoral injection, and lymphoscintigraphy. The hand-held gamma probe was utilized for SNB after tumoral resection during the same operating session. Out of 39 patients, 36 underwent SNB as the sole staging tool, while 3 patients received SNB in combination with elective neck dissection. Primary outcome was the 2-years neck recurrence-free survival (RFS). Secondary outcomes were the 2- and 5-years disease-specific survival (DSS). Additionally, sensitivity and negative predictive value (NPV) of the SNB technique were analyzed. RESULTS: Sentinel nodes were successfully identified in all 39 patients. An average of 4 nodes excised per patient. Positives SN were detected in 23% (9 in 39) cases, leading to subsequent selective neck dissection. Two cases of neck recurrence were observed, both considered as false negatives, occurring after an average of 3.5 months. Th median follow-up period was 48 months with a 2-year RFS of 95%. Sensitivity and NPV of the SNB technique were found to be 82% and 94%, respectively. Two and five years DSS were 84% and 71.7%, respectively. CONCLUSIONS: The results suggest that SNB in T1-T2 supraglottic SCC is a feasible and reliable technique for managing the neck in N0 early-stage patients. However, to establish its oncological equivalence with selective node dissection, further prospective and comparative studies are warranted. The findings of this study underscore the importance of ongoing research in refining and validating the role of SNB in the management of supraglottic SCC, potentially paving the way for more widespread adoption in clinical practice.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Hoste M, Van der Vorst S, Lawson G, et al. Reliability and outcomes of lymph nodes biopsy in cT1-cT2 N0 supraglottic laryngeal squamous cell carcinoma. Head Neck. 2024. PMID: 38421075. doi:10.1002/hed.27708

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。